IDEX Corporation Announces Pricing of Public Offering of Senior Notes

IDEX Corporation (NYSE: IEX) today announced the pricing of its public offering of $500.0 million principal amount of 2.625% Senior Notes due 2031. The notes will be senior obligations that rank equally with all of IDEX’s other senior unsecured indebtedness. Closing of the offering is expected to occur on May 28, 2021, subject to the satisfaction of customary closing conditions.

IDEX estimates that the net proceeds from the offering will be approximately $494.3 million, after deducting underwriting discounts and commissions and our estimated offering expenses. The company intends to use approximately $357.4 million of the net proceeds from this offering to redeem and repay all $350.0 million aggregate principal amount outstanding of the company’s 4.2% Senior Notes due December 15, 2021 and related accrued interest and redemption premiums, and the balance of the net proceeds will be used for general corporate purposes.

J.P. Morgan Securities LLC, BofA Securities, Inc. and Wells Fargo Securities, LLC are acting as joint book-running managers for the offering.

IDEX is making this offering pursuant to a shelf registration statement that automatically became effective upon filing with the Securities and Exchange Commission (the “SEC”). This offering will be made solely by means of a prospectus and prospectus supplement. You may obtain a copy of the preliminary prospectus supplement, the accompanying prospectus and the final prospectus supplement, when available, for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, any underwriter or any dealer participating in the offering will arrange to send you any of those documents upon request by contacting the joint book-running managers at:

J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179, Attn: Investment Grade Syndicate Desk; Telephone: (212) 834-4533.

BofA Securities, Inc., 200 North College Street (NC1-004-03-43), 3rd floor, Charlotte, North Carolina 28255-0001, Attn: Prospectus Department; Telephone: (800) 294-1322 or Email: dg.prospectus_requests@bofa.com

Wells Fargo Securities, LLC, 608 2nd Avenue South, Suite 1000, Minneapolis, Minnesota 55402, Attn: WFS Customer Service; Telephone (800) 645-3751 or Email: wfscustomerservice@wellsfargo.com

This press release shall not constitute a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Statements which are not historical facts and relate to future plans, events or performance are forward-looking statements that are based upon management’s current expectations and are subject to risks and uncertainties. The forward-looking statements are based on management’s current expectations and should not be construed in any manner as a guarantee that such events or results will in fact occur. All forward-looking statements speak only as of the date of this news release and IDEX undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Detailed information regarding risk factors with respect to IDEX and the offering are included in the company’s filings with the SEC, including the prospectus and prospectus supplement for the offering. The forward-looking statements included here are only made as of the date of this news release, and management undertakes no obligation to publicly update them to reflect subsequent events or circumstances, except as may be required by law. Investors are cautioned not to rely unduly on forward-looking statements when evaluating the information presented here. Any such forward-looking statements are not guarantees of future performances and actual results, developments and business decisions may differ from those contemplated by such forward-looking statements.

About IDEX

IDEX (NYSE: IEX) is a company that has undoubtedly touched your life in some way. In fact, IDEX businesses make thousands of products that are mission-critical components in everyday activities. Chances are the car you’re driving has a BAND-IT® clamp holding your side airbag safely in place. If you were ever in a car accident, a Hurst Jaws of Life® rescue tool may have saved your life. If you or a family member is battling cancer, your doctor may have tested your DNA in a quest to find the best targeted medicine for you. It’s likely your DNA test was run on equipment that contains components made by our growing IDEX Health & Science team. Founded in 1988 with three small, entrepreneurial manufacturing companies, we’re proud to say that we now call 40 diverse businesses around the world part of the IDEX family. With 7,000 employees and manufacturing operations in more than 20 countries, IDEX is a high-performing, global nearly $2.5 billion company committed to making trusted solutions that improve lives. IDEX shares are traded on the New York Stock Exchange under the symbol “IEX”.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210517005914/en/